These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 22805089

  • 21. Protein-enriched extracts from housefly (Musca domestica) maggots alleviates atherosclerosis in apolipoprotein E-deficient mice by promoting bile acid production and consequent cholesterol consumption.
    Xian C, Lai D, Liu J, Li S, Cao J, Chen K, Liang D, Fu N, Wang Y, Xiao M.
    Arch Insect Biochem Physiol; 2022 Oct; 111(2):e21951. PubMed ID: 35791048
    [Abstract] [Full Text] [Related]

  • 22. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages.
    Zeng Y, Peng Y, Tang K, Wang YQ, Zhao ZY, Wei XY, Xu XL.
    Biomed Pharmacother; 2018 May; 101():543-552. PubMed ID: 29505925
    [Abstract] [Full Text] [Related]

  • 23. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K, Mellal K, Zoccal KF, Rhainds D, Brissette L, Febbraio M, Marleau S, Ong H.
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [Abstract] [Full Text] [Related]

  • 24. Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARγ-LXRα-ABCA1 pathway.
    Yang CM, Lu IH, Chen HY, Hu ML.
    J Nutr Biochem; 2012 Jan; 23(1):8-17. PubMed ID: 21334870
    [Abstract] [Full Text] [Related]

  • 25. Phenylethanoid glycosides extract from Cistanche deserticola ameliorates atherosclerosis in apolipoprotein E-deficient mice and regulates intestinal PPARγ-LXRα-ABCA1 pathway.
    Jia X, Liu B, Xue J, Liu Y, Zhang J, Qin S, Zhang Y.
    J Pharm Pharmacol; 2023 Apr 17; 75(5):677-685. PubMed ID: 36840643
    [Abstract] [Full Text] [Related]

  • 26. Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaque.
    Wang H, Yang Y, Sun X, Tian F, Guo S, Wang W, Tian Z, Jin H, Zhang Z, Tian Y.
    Theranostics; 2018 Apr 17; 8(18):4969-4984. PubMed ID: 30429880
    [Abstract] [Full Text] [Related]

  • 27. QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-ABCA1 pathway.
    Xie J, Peng L, Wang T, Yang C, Chen N, Feng X, Wu T, Xu T, Chen Y.
    J Ethnopharmacol; 2023 Oct 28; 315():116684. PubMed ID: 37230281
    [Abstract] [Full Text] [Related]

  • 28. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies.
    Ozasa H, Ayaori M, Iizuka M, Terao Y, Uto-Kondo H, Yakushiji E, Takiguchi S, Nakaya K, Hisada T, Uehara Y, Ogura M, Sasaki M, Komatsu T, Horii S, Mochizuki S, Yoshimura M, Ikewaki K.
    Atherosclerosis; 2011 Nov 28; 219(1):141-50. PubMed ID: 21862012
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Knockdown of mesenchymal stem cell‑derived exosomal LOC100129516 suppresses the symptoms of atherosclerosis via upregulation of the PPARγ/LXRα/ABCA1 signaling pathway.
    Sun L, He X, Zhang T, Han Y, Tao G.
    Int J Mol Med; 2021 Dec 28; 48(6):. PubMed ID: 34608501
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10.
    Rubic T, Lorenz RL.
    Cardiovasc Res; 2006 Feb 01; 69(2):527-35. PubMed ID: 16336952
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice.
    Li S, Cao H, Shen D, Chen C, Xing S, Dou F, Jia Q.
    J Tradit Chin Med; 2019 Aug 01; 39(4):524-534. PubMed ID: 32186100
    [Abstract] [Full Text] [Related]

  • 34. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, Hoyt RF, Neufeld ED, Remaley AT, Fredrickson DS, Brewer HB, Santamarina-Fojo S.
    Proc Natl Acad Sci U S A; 2002 Jan 08; 99(1):407-12. PubMed ID: 11752403
    [Abstract] [Full Text] [Related]

  • 35. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway.
    Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z.
    J Am Soc Nephrol; 2003 Mar 08; 14(3):593-600. PubMed ID: 12595494
    [Abstract] [Full Text] [Related]

  • 36. Essential oil from Fructus Alpinia zerumbet ameliorates atherosclerosis by activating PPARγ-LXRα-ABCA1/G1 signaling pathway.
    Wang SQ, Xiang J, Zhang GQ, Fu LY, Xu YN, Chen Y, Tao L, Hu XX, Shen XC.
    Phytomedicine; 2024 Jan 08; 123():155227. PubMed ID: 38128398
    [Abstract] [Full Text] [Related]

  • 37. Salvianolic acid B accelerated ABCA1-dependent cholesterol efflux by targeting PPAR-γ and LXRα.
    Yue J, Li B, Jing Q, Guan Q.
    Biochem Biophys Res Commun; 2015 Jul 03; 462(3):233-8. PubMed ID: 25956064
    [Abstract] [Full Text] [Related]

  • 38. 22(R)-hydroxycholesterol and pioglitazone synergistically decrease cholesterol ester via the PPARγ-LXRα-ABCA1 pathway in cholesterosis of the gallbladder.
    Wang JM, Wang D, Tan YY, Zhao G, Ji ZL.
    Biochem Biophys Res Commun; 2014 Apr 25; 447(1):152-7. PubMed ID: 24704452
    [Abstract] [Full Text] [Related]

  • 39. Excessive exogenous cholesterol activating intestinal LXRα-ABCA1/G5/G8 signaling pathway can not reverse atherosclerosis in ApoE-/- mice.
    Yu X, Ding X, Feng H, Bi Y, Li Y, Shan J, Bian H.
    Lipids Health Dis; 2023 Apr 15; 22(1):51. PubMed ID: 37061692
    [Abstract] [Full Text] [Related]

  • 40. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y, Yao S, Yan H, Hu L, Yu C, Gao F, Xi C, Li H, Ye Y, Wang Y.
    Cardiovasc Res; 2016 Oct 15; 112(1):502-14. PubMed ID: 27460841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.